Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology

N Goldschlager; A E Epstein; G Naccarelli; B Olshansky; B Singh

doi:10.1001/archinte.160.12.1741

Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology

Arch Intern Med. 2000 Jun 26;160(12):1741-8. doi: 10.1001/archinte.160.12.1741.

Authors

N Goldschlager¹, A E Epstein, G Naccarelli, B Olshansky, B Singh

Affiliation

¹ Cardiology Division, University of California, San Francisco, San Francisco General Hospital, 94110, USA.

PMID: 10871966
DOI: 10.1001/archinte.160.12.1741

Abstract

Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.

Publication types

Guideline
Practice Guideline

MeSH terms

Administration, Oral
Amiodarone / administration & dosage
Amiodarone / adverse effects
Amiodarone / therapeutic use*
Anti-Arrhythmia Agents / administration & dosage
Anti-Arrhythmia Agents / adverse effects
Anti-Arrhythmia Agents / therapeutic use*
Arrhythmias, Cardiac / drug therapy
Drug Interactions
Humans
Infusions, Intravenous
Randomized Controlled Trials as Topic

Substances

Anti-Arrhythmia Agents
Amiodarone